These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 23318833)

  • 1. Effect of enzymatically modified isoquercitrin on preneoplastic liver cell lesions induced by thioacetamide promotion in a two-stage hepatocarcinogenesis model using rats.
    Fujii Y; Kimura M; Ishii Y; Yamamoto R; Morita R; Hayashi SM; Suzuki K; Shibutani M
    Toxicology; 2013 Mar; 305():30-40. PubMed ID: 23318833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
    Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
    Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppression effects of bilberry extracts and enzymatically modified isoquercitrin in early preneoplastic liver cell lesions induced by piperonyl butoxide promotion in a two-stage rat hepatocarcinogenesis model.
    Hara S; Morita R; Ogawa T; Segawa R; Takimoto N; Suzuki K; Hamadate N; Hayashi SM; Odachi A; Ogiwara I; Shibusawa S; Yoshida T; Shibutani M
    Exp Toxicol Pathol; 2014 Aug; 66(5-6):225-34. PubMed ID: 24680176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
    Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant enzymatically modified isoquercitrin suppresses the development of liver preneoplastic lesions in rats induced by beta-naphthoflavone.
    Shimada Y; Dewa Y; Ichimura R; Suzuki T; Mizukami S; Hayashi SM; Shibutani M; Mitsumori K
    Toxicology; 2010 Feb; 268(3):213-8. PubMed ID: 20045035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant apoptosis and regeneration of liver cells as a mechanism of liver-tumor promotion by β-naphthoflavone involving TNFα-signaling due to oxidative cellular stress in rats.
    Kuwata K; Shibutani M; Hayashi H; Shimamoto K; Hayashi SM; Suzuki K; Mitsumori K
    Toxicology; 2011 Apr; 283(1):8-17. PubMed ID: 21295105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor promotion by copper-overloading and its enhancement by excess iron accumulation involving oxidative stress responses in the early stage of a rat two-stage hepatocarcinogenesis model.
    Mizukami S; Ichimura R; Kemmochi S; Wang L; Taniai E; Mitsumori K; Shibutani M
    Chem Biol Interact; 2010 May; 185(3):189-201. PubMed ID: 20302851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indole-3-carbinol enhances oxidative stress responses resulting in the induction of preneoplastic liver cell lesions in partially hepatectomized rats initiated with diethylnitrosamine.
    Shimamoto K; Dewa Y; Ishii Y; Kemmochi S; Taniai E; Hayashi H; Imaoka M; Morita R; Kuwata K; Suzuki K; Shibutani M; Mitsumori K
    Toxicology; 2011 May; 283(2-3):109-17. PubMed ID: 21396975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Naphthoflavone enhances oxidative stress responses and the induction of preneoplastic lesions in a diethylnitrosamine-initiated hepatocarcinogenesis model in partially hepatectomized rats.
    Dewa Y; Nishimura J; Muguruma M; Jin M; Saegusa Y; Okamura T; Tasaki M; Umemura T; Mitsumori K
    Toxicology; 2008 Feb; 244(2-3):179-89. PubMed ID: 18164116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter-region hypermethylation and expression downregulation of Yy1 (Yin yang 1) in preneoplastic liver lesions in a thioacetamide rat hepatocarcinogenesis model.
    Abe H; Ogawa T; Wang L; Kimura M; Tanaka T; Morita R; Yoshida T; Shibutani M
    Toxicol Appl Pharmacol; 2014 Nov; 280(3):467-74. PubMed ID: 25151969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apocynin and enzymatically modified isoquercitrin suppress the expression of a NADPH oxidase subunit p22phox in steatosis-related preneoplastic liver foci of rats.
    Yoshida T; Murayama H; Kawashima M; Nagahara R; Kangawa Y; Mizukami S; Kimura M; Abe H; Hayashi SM; Shibutani M
    Exp Toxicol Pathol; 2017 Jan; 69(1):9-16. PubMed ID: 27789131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effect of enzymatically modified isoquercitrin on phenobarbital-induced liver tumor promotion in rats.
    Morita R; Shimamoto K; Ishii Y; Kuwata K; Ogawa B; Imaoka M; Hayashi SM; Suzuki K; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Nov; 85(11):1475-84. PubMed ID: 21445586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruptive cell cycle regulation involving epigenetic downregulation of Cdkn2a (p16(Ink4a)) in early-stage liver tumor-promotion facilitating liver cell regeneration in rats.
    Tsuchiya T; Wang L; Yafune A; Kimura M; Ohishi T; Suzuki K; Mitsumori K; Shibutani M
    Toxicology; 2012 Sep; 299(2-3):146-54. PubMed ID: 22659510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant enzymatically modified isoquercitrin or melatonin supplementation reduces oxidative stress-mediated hepatocellular tumor promotion of oxfendazole in rats.
    Nishimura J; Saegusa Y; Dewa Y; Jin M; Kawai M; Kemmochi S; Harada T; Hayashi SM; Shibutani M; Mitsumori K
    Arch Toxicol; 2010 Feb; 84(2):143-53. PubMed ID: 20033131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats.
    Nishimura J; Dewa Y; Okamura T; Muguruma M; Jin M; Saegusa Y; Umemura T; Mitsumori K
    Arch Toxicol; 2008 Sep; 82(9):641-54. PubMed ID: 18253720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analyses at the late stage of tumor promotion by oxfendazole in a rat hepatocarcinogenesis model.
    Dewa Y; Nishimura J; Jin M; Kawai M; Saegusa Y; Kenmochi S; Shimamoto K; Harada T; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Feb; 85(2):155-62. PubMed ID: 20502879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of GST-P-positive proliferative lesions facilitating lipid peroxidation with possible involvement of transferrin receptor up-regulation and ceruloplasmin down-regulation from the early stage of liver tumor promotion in rats.
    Mizukami S; Ichimura R; Kemmochi S; Taniai E; Shimamoto K; Ohishi T; Takahashi M; Mitsumori K; Shibutani M
    Arch Toxicol; 2010 Apr; 84(4):319-31. PubMed ID: 20091025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose DDT inhibition of hepatocarcinogenesis initiated by diethylnitrosamine in male rats: possible mechanisms.
    Kushida M; Sukata T; Uwagawa S; Ozaki K; Kinoshita A; Wanibuchi H; Morimura K; Okuno Y; Fukushima S
    Toxicol Appl Pharmacol; 2005 Nov; 208(3):285-94. PubMed ID: 15885732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of hepatocarcinogenesis by kojic acid in rat two-stage models after initiation with N-bis(2-hydroxypropyl)nitrosamine or N-diethylnitrosamine.
    Takizawa T; Imai T; Onose J; Ueda M; Tamura T; Mitsumori K; Izumi K; Hirose M
    Toxicol Sci; 2004 Sep; 81(1):43-9. PubMed ID: 15201437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylated chrysin, a dimethoxy flavone, partially suppresses the development of liver preneoplastic lesions induced by N-nitrosodiethylamine in rats.
    Khan MS; Halagowder D; Devaraj SN
    Food Chem Toxicol; 2011 Jan; 49(1):173-8. PubMed ID: 20955752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.